INVA FY 2013 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-96.5% YoY

Gross Profit

-$4M-90.0% margin

Operating Income

-$169M-3549.0% margin

Net Income

-$171M-3587.7% margin

EPS (Diluted)

$-1.67

Cash Flow

Operating Cash Flow

-$130M

Free Cash Flow

-$217M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$681M

Total Liabilities

$382M

Stockholders' Equity

$299M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$136M	-96.5%
Gross Profit	-$4M	$128M	-103.4%
Operating Income	-$169M	-$13M	-1199.0%
Net Income	-$171M	-$19M	-820.6%